About ADJUVANT GENOMICS, INC
Adjuvant Genomics is a company focused on improving prognosis and treatment outcomes for patients with Stage 1-2 non-small cell lung cancer (NSCLC) through personalized medicine solutions.
Identifying high-risk patients likely to experience cancer recurrencePredicting a patient’s responsiveness to adjuvant chemotherapySupporting faster transition to alternative adjuvant therapies for those unlikely to benefit from chemotherapy
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ADJUVANT GENOMICS, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.